Antimetastatic and Immunomodulating Effect of Water Extracts From Various Mushrooms

JAMS Journal of Acupuncture and Meridian Studies

Volumn 2, Issue 3, 2009, Pages 218-227

  Han, Sung Soo Ronald ^a   Cho, Chong Kwan ^a   Lee, Yeon Weol ^a   Yoo, Hwa Seung ^a  

^a Daejeon University   (South Korea)

Author keywords

colon26 L5 cell; IFN ; lung metastasis; Th1; Th2

Indexed keywords

ANTIMETASTATIC AGENT; BETA GLUCAN; CD11B ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; GLUCAN; INTERLEUKIN 4; M8; NK1.1 PROTEIN; PACHYMAN; PLANT EXTRACT; PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; IMMUNOLOGIC FACTOR; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARMILLARIA MELLEA; ARTICLE; B LYMPHOCYTE; CARBOHYDRATE ANALYSIS; CARCINOMA CELL; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CODYCEPS MILITARIS; COLON CARCINOMA; CONTROLLED STUDY; CORIOLUS VERSICOLOR; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GARNODERMA FRONDOSA; GRIFOLA; GRIFOLA FRONDOSA; HERICIUM ERINACEUS; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; IMMUNOMODULATION; LUNG METASTASIS; LYCIUM; LYCIUM CHINENSE; MEDICINAL PLANT; METASTASIS INHIBITION; MOUSE; MUSHROOM; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; AGARICALES; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COLON TUMOR; DISEASE MODEL; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG NEOPLASMS; METASTASIS; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

AGARICALES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-4; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; WATER;

EID: 69949092793     PISSN: 20052901     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2005-2901(09)60058-3     Document Type: Article

References (61)

1. Abbas A.K. Cellular and molecular immunology (1997), W.B. Saunders Co., USA 253-294
2. Lee S.J., Saiki I., Hayakawa Y., Nunome S., Yamada H., and Kim S.H. Antimetastatic and immunomodulating properties of a new herbal prescription. Bojung-bangam-tang. Int Immunopharmacol 3 (2003) 147-157
3. Harada M., Seta K., Ito O., Tamada K., Li T., Terao H., et al. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang). Immunopharmacol Immunotoxicol 17 (1995) 687-703
4. Ohnishi Y., Fujii H., Hayakawa Y., Sakukawa R., Yamaura T., Sakamoto T., et al. Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells. Jpn J Cancer Res 89 (1998) 206-213
5. Borchers A.T., Stern J.S., Hackmen R.M., Keen C.L., and Gershwin M.E. Mushrooms, tumors and immunity. Proc Soc Exp Biol Med 221 (1999) 281-293
6. Kim H.J., Chang W.K., Kim M.K., Lee S.S., and Choi B.Y. Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer 97 (2002) 531-535
7. Zaidman B.Z., Yassin M., Mahajna J., and Wasser S.P. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 67 (2005) 453-468
8. deVere White R.W., Hackman R.M., Soares S.E., Beckett L.A., and Sun B. Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology 60 (2002) 640-644
9. Chang R. Functional properties of edible mushrooms. Nutr Rev 54 (1996) 9193
10. th ed (1990), Official Methods of Analysis, Washington, DC
11. Chen Y.J., Shiao M.S., Lee S.S., and Wang S.Y. Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells. Life Sci 60 (1997) 2349-2359
12. Fujimiya Y., Suzuki Y., Katakura R., and Ebina T. Tumor-specific cytocidal and immunopotentiating effects of relatively low molecular weight products derived from the basidiomycete, Agaricus blazeiu Murill. Anticancer Res 19 (1999) 113-118
13. Chen Y.J., Shiao M.S., Lee S.S., and Wang S.Y. Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells. Life Sci 60 (1997) 2349-2359
14. Zhang W., Wang Y., and Hou Y. Effects of Chinese medicinal fungus water extract on tumor metastasis and some parameters of immune function. Int Immunopharmacol 4 (2004) 461-468
15. Borchers A.T., Keen C.L., and Gershwin M.E. Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood) 229 (2004) 393-406
16. Wasser S.P. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60 (2002) 258-274
17. Sagar S.M. Coriolus versicolor extracts: relevance in cancer management. Curr Oncol 14 (2007) 41-47
18. Donald I.A., and Andrew T.W. Integrative Oncology (2009), Oxford University Press, USA 130-138
19. Park B.W., Shin J.W., Cho J.H., Son C.G., Lee Y.W., Yoo H.S., et al. Effects of Armillaria mellea extract on macrophage and NK cell activity. Korean J Oriental Med 25 (2004) 161-170
20. Kodama N., Komuta K., and Nanba H. Effect of Maitake (Grifola frondosa) D-fraction on the activation of NK cells in cancer patients. J Med Food 6 4 (2003) 371-377
21. Mizuno T., Ohsawa K., Hagiwara N., and Kuboyama R. Fractionation and characterization of antitumor polysaccharides from Maitake, Grifola frondosa. Agric Biol Chem 50 (1986) 1679-1688
22. Ohno N., Adachi Y., Suzuki I., Sato K., Oikawa S., and Yadomae T. Characterization of the antitumor glucan obtained from liquid cultured Grifola frondosa. Chem Pharm Bull 34 (1986) 1709-1715
23. Shigesue K., Kodama N., and Nanba H. Effects of maitake (Grifola frondosa) polysaccharide on collagen-induced arthritis in mice. Jpn J Pharmacol 84 (2000) 293-300
24. Czop J.K., and Kay J. Isolation and characterization of β-glucan receptors on human mononuclear phagocytes. J Exp Med 173 (1991) 1511-1520
25. Tabata K., Ito W., Kojima T., Kawabata S., and Misaki A. Ultrasonic degradation of schizophyllan, an antitumor polysaccharide produced by Schizophyllum commune Fries. Carbohydr Res 89 (1981) 121-135
26. Yanaki T., Ito W., Tabata K., Kojima T., Norisuye T., Takano N., et al. Correlation between the antitumor activity of a polysaccharide schizophyllan and its triple-helical conformation in dilute aqueous solution. Biophys Chem 17 (1983) 337-342
27. Lee H., Kim Y.J., Kim H.W., Lee D.H., Sung M.K., and Park T. Induction of apoptosis by Cordyceps militaris through activation of caspase-3 in leukemia HL-60 cells. Biol Pharm Bull 29 (2006) 670-674
28. Yoo H.S., Shin J.W., Cho J.H., Son C.G., Lee Y.W., Park S.Y., et al. Effects of Cordyceps militaris extract on angiogenesis and tumor growth. Acta Pharmacol Sin 25 (2004) 657-665
29. Mizuno T., Wasa T., Ito H., Suzuki C., and Ukai N. Antitumor active polysaccharides isolated from the fruiting body of Hericium erinaceum, an edible and medicinal mushroom called yamabushitake or houtou. Biosci Biotechnol Biochem 56 (1992) 347-348
30. Stadler M., Mayer A., Anke H., and Sterner O. Fatty acids and other compounds with nematicidal activity from cultures of Basidiomycetes. Planta Med 60 (1994) 128-132
31. Son C.G., Shin J.W., Cho J.H., Cho C.K., Yun C.H., Chung W., et al. Macrophage activation and nitric oxide production by water soluble components of Hericium erinaceum. Int Immunopharmacol 6 (2006) 1363-1369
32. Son C.G., Shin J.W., Cho J.H., Cho C.K., Yun C.H., and Han S.H. Induction of murine interleukin-1 beta expression by water soluble components from Hericium erinaceum. Acta Pharmacol Sin 27 (2006) 1058-1064
33. Lin Z.B., and Zhang H.N. Antitumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 25 (2004) 1387-1395
34. Cui J., and Chisti Y. Polysaccharopeptides of Coriolus versicolor : physiological activity, uses, and production. Biotechnol Adv 21 (2003) 109-122
35. Fisher M., and Yang L.X. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res 22 (2002) 1737-1754
36. Ebina T., Kohya H., Yamaguchi T., and Ishida N. Antimetastatic effect of biological response modifiers in "double grafted tumor system". Jpn J Cancer Res 77 (1986) 1034-1042
37. Fujimiya Y., Suzuki Y., Oshima K., Kobori H., Moriguchi K., Nakashima H., et al. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunol Immunother 46 (1998) 147-159
38. Itoh H., Ito H., Amano H., and Noda H. Inhibitory action of α (1→6)-beta-D-glucan-protein complex (FIII-2-b) isolated from Agaricus blazei Murill ("himematsutake") on Meth A fibrosarcoma-bearing mice and its antitumor mechanism. Jpn J Pharmacol 66 (1994) 265-271
39. Mizuno M., Morimoto M., Minato K., and Tsuchida H. Polysac charides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Biosci Biotechnol Biochem 62 (1998) 434-437
40. Mizuno M., Minato K., Ito H., Kawade M., Terai H., and Tsuchida H. Antitumor polysaccharide from the mycelium of liquidcultured Agaricus blazei mil. Biochem Mol Biol Int 47 (1999) 707-714
41. Gan L., Zhang S.H., Liu Q., and Xu H.B. A polysaccharideprotein complex from Lyciumbarbarum upregulates cytokine expression in human peripheral blood mononuclearcells. Eur J Pharmacol 471 (2003) 217-222
42. Gan L., Hua Zhang S., Liang Yang X., and Bi Xu H. Immunomodulation and antitumor activity by a polysaccharideprotein complex from Lycium barbarum. Int Immunopharmacol 4 (2004) 563-569
43. Ha K.T., Yoon S.J., Choi D.Y., Kim D.W., Kim J.K., and Kim C.H. Protective effect of Lycium chinense fruit on carbon tetrachloride-induced hepatotoxicity. J Ethnopharmacol 96 3 (2005) 529-535
44. Gong H., Shen P., Jin L., Xing C., and Tang F. Therapeutic effects of Lycium barbarum polysaccharide (LBP) on irradiation or chemotherapy-induced myelosuppressive mice. Cancer Biother Radiopharm 20 (2005) 155-162
45. Gong H., Shen P., Jin L., Xing C., and Tang F. Therapeutic effects of Lycium barbarum polysaccharide (LBP) on mitomycin C (MMC)-induced myelosuppressive mice. J Exp Ther Oncol 4 (2004) 181-187
46. Zhang M., Chen H., Huang J., Li Z., Zhu C., and Zhang S. Effect of Lycium barbarum polysaccharide on human hepatoma QGY7703 cells: inhibition of proliferation and induction of apoptosis. Life Sci 76 (2005) 2115-2124
47. Chao J.C., Chiang S.W., Wang C.C., Tsai Y.H., and Wu M.S. Hot water-extracted Lycium barbarum and Rehmannia glutinosa inhibit proliferation and induce apoptosis of hepato-cellular carcinoma cells. World J Gastroenterol 12 (2006) 4478-4484
48. Chen Z., Kwong Huat Tan B., and Chan S.H. Activation of T lymphocytes by polysaccharideprotein complex from Lycium barbarum L. Int Immunopharmacol 8 (2008) 1663-1671
49. Zola H., Swart B., Nicholson I., Aasted B., Bensussan A., Boumsell L., et al. CD molecules 2005: human cell differentiation molecules. Blood 106 (2005) 3123-3126
50. Fiebig H., Behn I., Gruhn R., Typlt H., Kupper H., and Ambrosius H. Characterization of a series of monoclonal antibodies against human T cells. Allerg Immunol (Leipz) 30 (1984) 242-250 [In German]
51. Miceli M.C., and Parnes J.R. Role of CD4 and CD8 in T cell activation and differentiation. Adv Immunol 53 (1993) 59-122
52. th Edition (2007), WH Freeman, New York
53. Nakamori M., Iwahashi M., Nakamura M., Ueda K., Zhang X., and Yamaue H. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer. Clin Cancer Res 9 (2003) 2357-2365
54. Nishimura T., Iwakabe K., Sekimoto M., Ohmi Y., Yahata T., Nakui M., et al. Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo. J Exp Med 190 (1999) 617-627
55. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17 (1996) 138-146
56. Featon E.R., Pardoll D.M., Itaya T., Golumbek P., Levitsy H.I., Simons J.W., et al. Interleukin 2 production by tumor bypasses T-helper function in the generation of an anti-tumor response. Cell 60 (1990) 397-403
57. Tepper R.I., Pattengale P.K., and Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57 (1989) 503-512
58. Allione A., Consalvo M., Nanni P., Lonllini P.L., Cavallo F., Giovarelli M., et al. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with IL-2, IL-4, IL-6, IL-7, IL-10, TNF-α, GM-CSF, and IFN-γ gene or admixed with conventional adjuvants. Cancer Res 54 (1994) 6022-6026
59. + cytotoxic T-lymphocyte activation in mice. Cancer Res 56 (1996) 5005-5011
60. Obiri N.I., Hillman G.G., Haas G.P., Sud S., and Puri R.K. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J Clin Invest 91 (1993) 88-93
61. Bosco M., Giovarelli M., Forni M., Modesti A., Scarpa S., Masuelli L., et al. Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J Immunol 145 (1990) 3136-3243